Clinical trial population adjacent: Obese individuals with higher adiposity, MASLD, T2D/high HbA1c, and/or significant liver fat and metabolic panel improvement goals
The standard KLOW dosage is 3.2 mg (10 units) per injection: daily during the activation phase in weeks 14, 5x per week during the remodeling phase in weeks 58, and 2-3x per week during maintenance in weeks 912
These may include nausea, bloating, or diarrhea
When it comes to peptides that genuinely help with weight loss, the strongest evidence lies with FDA-approved prescription medications
Subgroup analyses evaluated four key factors: administration route efficacy, daily dosage, age group and clinical conditions that may affect vitamin B12 metabolism (e.g., underlying pathology)